Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Where are the shorts? I don't see them

<< Previous

Bullboard Posts

Next >>

Post by whisky11on Jul 28, 2021 12:03pm

162 Views

Post# 33616925

Where are the shorts? I don't see them

Do you see them? what else you see? It says in the company description as long as it doesn't hit the bull's-eye it will be unprofitable.
Stock price is little bit higher than before RS. The value of
Claritas is in R-107 and board of directors, those guys and ladies are top World class researches in nitrogen oxide.
In dollar value trade today it's a bit over C$20,000 you're telling me that the shorters go after 1% of $20,000 to make "fortune".

CLASCLARITAS PHARMACCA

$ 0.50

-0.02

(-3.85%)

Bid (Size)

0.49 (49)

Ask (Size)

0.50 (111)

Volume

43,151

<< Previous

Bullboard Posts